Dr Stephen Wren

About

I am highly experienced in medicinal chemistry and have worked on a diverse set of biological targets over many disease areas in several organisations (Xenova, Argenta Discovery and Summit plc). I have an extensive track record in project and team management, intellectual property, drug discovery in many therapeutic areas and helped lead the chemistry effort directed towards the identification of SMTC1100 (Summit's Duchenne Muscular Dystrophy drug, currently undergoing clinical evaluation).

I have also conducted research at the Alzheimer's Research UK Oxford Drug Discovery Institute and taught at Oxford University (organic chemistry, pharmaceutical chemistry and biomedical sciences). I was a fellow of St Hilda's College, Oxford, between 2015 and 2018.

Academic responsibilities

Lecturer in Organic and Pharmaceutical Chemistry

Qualifications

  • PhD (Cambridge University)
  • BSc (Hons)
  • FHEA

Teaching and learning

Research

Organic and medicinal chemistry.

Chemical and biosensors for medical and environmental applications.

Research student supervision

Publications

Number of items: 3.

Article

Ritchie, James, Sykes, Andy, Weber, Peter and Wren, Stephen P. (2019) Immuno-oncology : the next generation of breakthrough therapies. Highlights from The Society for Medicines Research Symposium. Oxford, UK - June 21, 2019. Drugs of the Future, 44(7), pp. 599-604. ISSN (print) 0377-8282

Book Section

Wren, Stephen P. (2020) Tricyclic systems : central carbocyclic ring with fused five- and six-membered rings. In: UNSPECIFIED, (ed.) Comprehensive Heterocyclic Chemistry IV. Elsevier. (In Press)

Database or Web Resource

Wren, Stephen P. (2020) Tricyclic systems : central carbocyclic ring with fused five- and six-membered rings. https://doi.org/10.1016/B978-0-12-409547-2.14896-6

This list was generated on Tue Jun 2 05:26:26 2020 BST.

Social media

LinkedIn